{"id":6993,"date":"2024-03-04T19:12:04","date_gmt":"2024-03-04T19:12:04","guid":{"rendered":"https:\/\/www.sicklecelldisease.org\/?p=6993"},"modified":"2024-10-01T20:51:10","modified_gmt":"2024-10-01T20:51:10","slug":"scdaa-joins-the-igt-patient-advocacy-advisory-council","status":"publish","type":"post","link":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/","title":{"rendered":"SCDAA Joins the IGT Patient Advocacy Advisory Council"},"content":{"rendered":"

\"\"SCDAA is pleased to announce that we have joined the Institute for Gene Therapies (IGT) Patient Advocacy Advisory Council. IGT advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. SCDAA is proud to support this mission as an advisory council member. Learn more about IGT.<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

SCDAA is pleased to announce that we have joined the Institute for Gene Therapies (IGT) Patient Advocacy Advisory Council. IGT advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. SCDAA is proud to support this mission as an advisory council member. Learn more about […]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6993","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"yoast_head":"\nSCDAA Joins the IGT Patient Advocacy Advisory Council - Sickle Cell Disease Association of America Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SCDAA Joins the IGT Patient Advocacy Advisory Council - Sickle Cell Disease Association of America Inc.\" \/>\n<meta property=\"og:description\" content=\"SCDAA is pleased to announce that we have joined the Institute for Gene Therapies (IGT) Patient Advocacy Advisory Council. IGT advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. SCDAA is proud to support this mission as an advisory council member. Learn more about […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/\" \/>\n<meta property=\"og:site_name\" content=\"Sickle Cell Disease Association of America Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-04T19:12:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-01T20:51:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo-1024x472.png\" \/>\n<meta name=\"author\" content=\"Emma Day\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Emma Day\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/\",\"url\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/\",\"name\":\"SCDAA Joins the IGT Patient Advocacy Advisory Council - Sickle Cell Disease Association of America Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo-1024x472.png\",\"datePublished\":\"2024-03-04T19:12:04+00:00\",\"dateModified\":\"2024-10-01T20:51:10+00:00\",\"author\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#primaryimage\",\"url\":\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo.png\",\"contentUrl\":\"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo.png\",\"width\":7200,\"height\":3316},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sicklecelldisease.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SCDAA Joins the IGT Patient Advocacy Advisory Council\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#website\",\"url\":\"https:\/\/www.sicklecelldisease.org\/\",\"name\":\"Sickle Cell Disease Association of America Inc.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sicklecelldisease.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3\",\"name\":\"Emma Day\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g\",\"caption\":\"Emma Day\"},\"url\":\"https:\/\/www.sicklecelldisease.org\/author\/emma\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SCDAA Joins the IGT Patient Advocacy Advisory Council - Sickle Cell Disease Association of America Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/","og_locale":"en_US","og_type":"article","og_title":"SCDAA Joins the IGT Patient Advocacy Advisory Council - Sickle Cell Disease Association of America Inc.","og_description":"SCDAA is pleased to announce that we have joined the Institute for Gene Therapies (IGT) Patient Advocacy Advisory Council. IGT advocates for a modernized regulatory and reimbursement framework that encourages the development of transformative gene therapies and promotes patient access. SCDAA is proud to support this mission as an advisory council member. Learn more about […]","og_url":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/","og_site_name":"Sickle Cell Disease Association of America Inc.","article_published_time":"2024-03-04T19:12:04+00:00","article_modified_time":"2024-10-01T20:51:10+00:00","og_image":[{"url":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo-1024x472.png","type":"","width":"","height":""}],"author":"Emma Day","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Emma Day"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/","url":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/","name":"SCDAA Joins the IGT Patient Advocacy Advisory Council - Sickle Cell Disease Association of America Inc.","isPartOf":{"@id":"https:\/\/www.sicklecelldisease.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#primaryimage"},"image":{"@id":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#primaryimage"},"thumbnailUrl":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo-1024x472.png","datePublished":"2024-03-04T19:12:04+00:00","dateModified":"2024-10-01T20:51:10+00:00","author":{"@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3"},"breadcrumb":{"@id":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#primaryimage","url":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo.png","contentUrl":"https:\/\/www.sicklecelldisease.org\/wp-content\/uploads\/2023\/08\/IGT-Logo.png","width":7200,"height":3316},{"@type":"BreadcrumbList","@id":"https:\/\/www.sicklecelldisease.org\/2024\/03\/04\/scdaa-joins-the-igt-patient-advocacy-advisory-council\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sicklecelldisease.org\/"},{"@type":"ListItem","position":2,"name":"SCDAA Joins the IGT Patient Advocacy Advisory Council"}]},{"@type":"WebSite","@id":"https:\/\/www.sicklecelldisease.org\/#website","url":"https:\/\/www.sicklecelldisease.org\/","name":"Sickle Cell Disease Association of America Inc.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sicklecelldisease.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/22ff615054be6fdd3e861004652dd8e3","name":"Emma Day","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.sicklecelldisease.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/61d0c1099d251a9cdc20252cca50e230?s=96&d=mm&r=g","caption":"Emma Day"},"url":"https:\/\/www.sicklecelldisease.org\/author\/emma\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/6993","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/comments?post=6993"}],"version-history":[{"count":3,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/6993\/revisions"}],"predecessor-version":[{"id":7340,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/posts\/6993\/revisions\/7340"}],"wp:attachment":[{"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/media?parent=6993"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/categories?post=6993"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sicklecelldisease.org\/wp-json\/wp\/v2\/tags?post=6993"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}